Phase 3 Trial Reports Promising Results for New COVID Treatment
'The data look quite promising and other treatments have now fallen by the wayside,' said Paul Sax, MD, of Brigham and Women's Hospital in Boston.
Stay updated with breaking news from Alacyclovir. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
'The data look quite promising and other treatments have now fallen by the wayside,' said Paul Sax, MD, of Brigham and Women's Hospital in Boston.
Researchers review the symptoms, diagnosis, and treatment of ocular Mpox syndrome in men living with HIV infection.
Pharmaceutical companies that made billions from the pandemic over the past 2 years selling vaccines and treatments are now up against a steep COVID cliff and investor pressure to spend their windfalls wisely.
Additional studies are needed for accurate booster-dose timing as new variants emerge, according to researchers.
The FDA announced the changes Wednesday in letters sent to the drugs' manufacturers, Pfizer and Merck.